CELAID THERAPEUTICS
Celaid Therapeutics specializes in manufacturing and sales of regenerative medicine products utilizing human hematopoietic stem cells.
CELAID THERAPEUTICS
Industry:
Biotechnology Health Care Manufacturing Medical
Founded:
2020-10-08
Address:
Hongo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.celaidtx.com
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics WordPress Google Universal Analytics Font Awesome Euro AJAX Libraries API Pound Sterling
Official Site Inspections
http://www.celaidtx.com
- Host name: sv3132.xserver.jp
- IP address: 202.254.234.133
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "Celaid Therapeutics"
Top - Celaid Therapeutics - Official Site
We have succeeded in developing technology for the mass propagation of functional HSCs with blood reconstruction ability. In addition, since the technology does not use animal-derived …See details»
about - Celaid Therapeutics - Official Site
Company name: Celaid Therapeutics Inc. Established: October 8, 2020: President and CEO: Nobuyuki Arakawa: Paid-in capital: 510,509,600 JPY: Address ＜Headquarters＞See details»
セレイドセラピューティクス - 細胞治療（造血幹細胞）
造血幹細胞を活用して次世代医療への応用を目指すバイオベンチャー企業です。従来困難だったヒト造血幹細胞の体外増幅を実現、高品質・大量に製造を可能にしました。次世代の再生医 …See details»
Celaid Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number +81 5036127767 Celaid Therapeutics specializes in manufacturing and sales of regenerative medicine …See details»
Celaid Therapeutics - LinkedIn
Celaid Therapeutics is a Japan-based biotechnology company, which has developed a platform technology to efficiently expand hematopoietic stem cells ex vivo without choosing its origins, …See details»
Celaid Therapeutics Inc.｜投資先企業｜UTEC-The University of …
Celaid Therapeutics provides products and services that utilize human hematopoietic stem cell (HSC) expansion technology. Their focuses are research and discovery support for …See details»
Celaid Therapeutics Company Profile 2024: Valuation, Funding ...
Celaid Therapeutics General Information Description. Developer of a regenerative medicine start-up intended to develop cell therapy products. The company's medicines are developed using …See details»
Celaid Therapeutics Inc. | NEDO
Program name. Deep-Tech Startups Support Program. Research theme. R&D Cost of HSC Expansion Platform Technology for Cell and Gene Therapy CompaniesSee details»
Celaid Therapeutics | VentureRadar
Website: https://celaidtx.com/ Develops advanced cell therapies specializing in hematopoietic stem cells, offering innovative treatments for blood cancers and genetic ...See details»
Chosen for the New Energy and Industrial Technology …
Mar 22, 2024 Chosen for the New Energy and Industrial Technology Development Organization (NEDO) Deep Tech Startup Support Project (DTSU) ... TEL：+81-50-3612-7767／E …See details»
セレイドセラピューティクス株式会社｜KBIC 神戸医療産業都市 …
「ヒト造血幹細胞の体外増幅技術による血液・免疫系疾患治療のための細胞治療製品の開発 事業概要. セレイドセラピューティクス株式会社は、人の血液の源となる造血幹細胞を利用して …See details»
Celaid Therapeutics on LinkedIn: #startups #celaid #cic
Celaid will speak at the "Mizuho Bank CIC Tokyo" Global Pitch Event on December 16. Click here to sign up to watch our pitch!! https://lnkd.in/gz8Q_qnr #startups #Celaid #CICSee details»
C4Uとセレイドセラピューティクス、造血幹細胞遺伝子治療製品 …
Dec 14, 2023 セレイドセラピューティクス株式会社のプレスリリース（2023年12月14日 11時00分）c4uとセレイドセラピューティクス、造血幹細胞遺伝子治療製品の ...See details»
Contact - Celaid Therapeutics - Official Site
If the inquiry form does not function properly, please send a direct inquiry to contact[a]celaidtx.com (use “@” in place of [a]). Entrepreneur Lab., South Clinical Research …See details»
新たな細胞治療製品の開発に取り組むセレイドセラピューティク …
Aug 3, 2023 セレイドセラピューティクス株式会社のプレスリリース（2023年8月3日 11時00分）新たな細胞治療製品の開発に取り組むセレイドセラピ ...See details»
新たな細胞治療を開発するセレイドセラピューティクス株式会社 …
Oct 25, 2022 セレイドセラピューティクス株式会社のプレスリリース（2022年10月25日 11時00分）新たな細胞治療を開発するセレイドセラピューティクス株式会社 ...See details»
Celaid Therapeutics - VentureRadar
Auto Analyst Score: 62 | celaidtx.com. VentureRadar Popularity. Medium. VentureRadar Popularity: Medium. The popularity score combines profile views, clicks and the number of …See details»
Celaid Therapeutics Email Format | celaidtx.com Emails
The most common Celaid Therapeutics email format. is [first].[last] (ex. [email protected]), which is being used by 100.0% of Celaid Therapeutics work email addresses. Celaid …See details»
Press Release - celaidtx.com
Mar 22, 2024 Organization (NEDO) Deep Tech Startup Support Project (DTSU) • Celaid Therapeutics Inc. with its CEO, Nobuyuki Arakawa, is pleased to announce today that it has …See details»
セレイドセラピューティクス株式会社の会社情報と資金調達
【nikkei compass】セレイドセラピューティクス株式会社は、ヒト造血幹細胞の増幅技術を用いた再生医療製品を開発する東京大学発ベンチャー企業。See details»